The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients [version 3; peer review: 2 approved] by Philipp T. Möller, Patty P.A. Dhooge, Andrew J. Lotery, Camiel J.F. Boon, Maurizio Battaglia Parodi, Philipp Herrmann, Mario G. Fsadni, Wolfgang Klein, Oliver Jungmann, Thomas H. Wheeler-Schilling, Frank G. Holz, Hans Müller, Tobias M. Peters, Steffen Schmitz-Valckenberg, Carel B. Hoyng, Katarina Stingl

Get full text